| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 09/27/2006 | EP1703908A1 Aryl sulfonamide compounds and uses related thereto |
| 09/27/2006 | EP1703797A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 09/27/2006 | EP1592696B1 Salts comprising cyanoborate anions |
| 09/27/2006 | EP1565445B1 Process for the preparation of imidazolyl compounds |
| 09/27/2006 | CN1839132A N3-substituted imidazopyridine-derivatives as C-KIT inhibitors |
| 09/27/2006 | CN1839122A Ioninc liquids based on imidazolium salts incorporating a nitrile functionality |
| 09/27/2006 | CN1276914C Novel cyclohexyl sulphones |
| 09/26/2006 | US7112681 bifonazole; reduction of 4-phenyl-benzophenone, then subsequent reaction of the biphenyl phenyl carbinol with imidazole in solid phase under microwave energy |
| 09/26/2006 | US7112601 Cycloalkyl heterocycles for treating hepatitis C virus |
| 09/26/2006 | US7112337 Liposome mixture of a lipid that is neutral in charge at physiologic pH and positively charged at pH values less than physiological pH, and a lipid joined to a hydrophilic polymer by an aromatic disulfide linkage, associated with a nucleic |
| 09/26/2006 | CA2424965C Novel coupler for use in oxidative hair dyeing |
| 09/21/2006 | WO2006099459A1 Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine |
| 09/21/2006 | WO2006097766A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/21/2006 | WO2006097261A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/21/2006 | WO2006048152A3 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 09/21/2006 | US20060211863 Process for the preparation of opioid modulators |
| 09/21/2006 | US20060211845 1-Imidazolymethyl -substituted -2-naphtols and their use as accelerators for low - temperature curing |
| 09/21/2006 | US20060211717 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/21/2006 | US20060211712 E.g., 6'-Chloro-3-methyl-5'-{[2-(2-oxo-3-pyridin-2-yl-2,3-dihydro-1H-benzimidazol-1-yl)acetyl]amino}-spiro[imidazolidine-4,2'-indane]-2,5-dione; treating migraines and cluster headaches optionally with serotonin agonists, analgesics, anti-inflammatory agents, anti-hypertensives and/or anticonvulsants. |
| 09/21/2006 | CA2600868A1 Quinazolinone t-type calcium channel antagonists |
| 09/21/2006 | CA2600508A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/21/2006 | CA2599476A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/20/2006 | EP1622877B1 Method for the production of ionic liquids containing alkyl sulphate and functionalised alkyl sulphate-anions |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | CN1835958A N-heterocyclic carbenes that can be immobilized |
| 09/20/2006 | CN1835914A New benzamides as PPAR[upsilon] modulators |
| 09/20/2006 | CN1276530C Novel onium salt, electrolyte for nonaqueous cell containing novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/19/2006 | US7109348 Cyclizing a diimine at or below room temperature by reaction with paraformaldehyde and a protic acid; particularly reacting a 1,3, diaryldiazabutadiene, 1,3, dialkyldiazabutadiene, or 1,3, arylalkyldiazabutadiene, paraformaldehyde and HCl, HBF4, or HPF6 to form an imidazolium salt |
| 09/19/2006 | US7109227 Anticancer agents |
| 09/19/2006 | US7109216 For therapy of psychiatric and neurological disorders |
| 09/19/2006 | US7108846 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 09/19/2006 | CA2149459C Acylated aminoalkanimidazoles and -triazoles |
| 09/14/2006 | WO2006096129A1 Method and use of acidified modified polymers to bind biocides in paints |
| 09/14/2006 | WO2006096128A1 Method and use of nanoparticles to bind biocides in paints |
| 09/14/2006 | WO2006095542A1 Pharmaceutical composition comprising amine compound |
| 09/14/2006 | WO2006084176A3 Compounds and compositions as ppar modulators |
| 09/14/2006 | WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 09/14/2006 | US20060205954 Process for the hydrogenation of aromatic compounds |
| 09/14/2006 | US20060205943 Process for preparing xanthine phosphodiesterase V inhibitors and precursers thereof |
| 09/14/2006 | US20060205742 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 09/14/2006 | US20060204587 Use of film coating as taste-masking coating of oral dosage forms |
| 09/14/2006 | CA2600649A1 Method and use of acidified modified polymers to bind biocides in paints |
| 09/14/2006 | CA2600646A1 Method and use of nanoparticles to bind biocides in paints |
| 09/13/2006 | EP1699900A2 Composition and method for preventing fouling in (meth)acrylic acid processes |
| 09/13/2006 | EP1699455A1 Heterocyclic aspartyl protease inhibitors |
| 09/13/2006 | EP1246617B1 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of ovarian cancer |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1832944A Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 09/13/2006 | CN1832928A 5-membered heterocycle-based p38 kinase inhibitors |
| 09/13/2006 | CN1832761A Thiotungstate analogues and uses thereof |
| 09/13/2006 | CN1830966A Method for preparing 2-alkyl imidazole 4,5-dicarboxylic acid |
| 09/13/2006 | CN1274677C Method for preparing rilrnenidine |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | CA2307037C Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/12/2006 | CA2235986C Inhibitors of protein isoprenyl transferases |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/08/2006 | WO2006092492A1 $g(g) crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 09/08/2006 | WO2006092430A1 Selective inhibitors of human corticosteroid synthases |
| 09/08/2006 | WO2006073923A3 Phosphagen synthesis |
| 09/07/2006 | US20060199853 Analogs of 4-hydroxyisoleucine and uses thereof |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/07/2006 | DE102005009705A1 Use of naphthalene derivatives for the treatment of hyperaldosteronism, heart failure, myocardial fibrosis, hypercortisolism and diabetes mellitus |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698618A1 Benzamide derivative |
| 09/06/2006 | EP1698606A1 Fluorinating agent and method for producing fluorine-containing compound using same |
| 09/06/2006 | EP1698335A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 09/06/2006 | EP1697352A2 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 09/06/2006 | EP1697330A1 Method for the production of n,n -carbonyldiazoles |
| 09/06/2006 | EP1697312A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 09/06/2006 | EP1697292A1 Method for the production of tetrahydrogeranylacetone |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof |
| 09/06/2006 | CN1273464C Optically pure R-(+)- Omeprazole prepn process |
| 09/06/2006 | CN1273453C Intermediate for biotin and process for producing the same |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102012 Process for preparing N,N'-carbonyldiazoles |
| 09/05/2006 | US7102010 Pesticides, drugs, fungicides; reacting p-toluenesulfony isocyanate with phosphorus oxychloride or phosgene in presence of phase transfer agent and base |
| 09/05/2006 | US7101902 2-guanidinylimidazolidinedione compounds and methods of making and using thereof |
| 09/05/2006 | US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | CA2187484C Process for the preparation of enantiomerically pure imidazolyl compounds |
| 08/31/2006 | WO2006090657A1 Process for producing boron tetrafluoride, boron tetrafluoride produced by said process, electrolysis solution for electric double layer capacitor using said boron tetrafluoride, and process for producing said electrolysis solution |
| 08/31/2006 | WO2006089664A2 Heterocyclylamide-substituted imidazoles |
| 08/31/2006 | WO2006066133A3 Histone deacetylase inhibitors |
| 08/31/2006 | US20060194965 Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 08/31/2006 | US20060194857 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194744 Illudin analogs useful as antitumor agents |
| 08/31/2006 | US20060194328 Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins |
| 08/31/2006 | DE102005008183A1 New heterocyclylamide-substituted imidazole compounds useful to treat or prevent viral infections |
| 08/30/2006 | EP1695968A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 08/30/2006 | EP1695705A1 Compounds effecting glucokinase |
| 08/30/2006 | EP1694650A1 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |